CPXM2 Antibody (3E4)
Novus Biologicals, part of Bio-Techne | Catalog # H00119587-M01
Key Product Details
Species Reactivity
Human
Applications
ELISA
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2b Kappa Clone # 3E4
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
CPXM2 (NP_937791, 190 a.a. ~ 279 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. DLQQWIEVDARRLTRFTGVITQGRNSLWLSDWVTSYKVMVSNDSHTWVTVKNGSGDMIFEGNSEKEIPVLNELPVPMVARYIRINPQSWF
Reactivity Notes
Human. Other species not tested.
Specificity
CPXM2 (3E4)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2b Kappa
Applications for CPXM2 Antibody (3E4)
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Antibody reactive against recombinant protein on ELISA.
Formulation, Preparation, and Storage
Purification
IgG purified
Formulation
In 1x PBS, pH 7.4
Preservative
No Preservative
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Background: CPXM2
Alternate Names
carboxypeptidase Hlo, carboxypeptidase X (M14 family), member 2, carboxypeptidase-like protein X2, EC 3.4.17, EC 3.4.17.3, inactive carboxypeptidase-like protein X2,4632435C11Rik, UNQ676
Entrez Gene IDs
119587 (Human)
Gene Symbol
CPXM2
UniProt
Additional CPXM2 Products
Product Documents for CPXM2 Antibody (3E4)
Product Specific Notices for CPXM2 Antibody (3E4)
This product is produced by and distributed for Abnova, a company based in Taiwan.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...